Literature DB >> 27042752

Ovarian Cancer, the Revised FIGO Staging System, and the Role of Imaging.

Sanaz Javadi1, Dhakshina M Ganeshan2, Aliya Qayyum2, Revathy B Iyer2, Priya Bhosale2.   

Abstract

OBJECTIVE: It is now recognized that ovarian cancer includes a heterogeneous group of malignant epithelial tumors originating from the ovaries, fallopian tubes, or peritoneum. This development has prompted the International Federation of Gynecology and Obstetrics (FIGO) to issue a revised staging system that can provide prognostic information and guidance on personalized management of ovarian cancer.
CONCLUSION: We review the epidemiology of ovarian cancer, the new FIGO staging system, and the role of imaging in the assessment, staging, and follow-up of ovarian cancer.

Entities:  

Keywords:  International Federation of Gynecology and Obstetrics (FIGO); ovarian cancer; staging

Mesh：

Year:  2016        PMID： 27042752     DOI： 10.2214/AJR.15.15199

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN： 0361-803X            Impact factor:   3.959


  49 in total

1.  Radiomics based on multisequence magnetic resonance imaging for the preoperative prediction of peritoneal metastasis in ovarian cancer.

Authors:  Xiao-Li Song; Jia-Liang Ren; Ting-Yu Yao; Dan Zhao; Jinliang Niu
Journal:  Eur Radiol       Date:  2021-05-04       Impact factor: 5.315

2.  MicroRNA-19b promotes the migration and invasion of ovarian cancer cells by inhibiting the PTEN/AKT signaling pathway.

Authors:  Dan-Tong Liu; Hai-Rong Yao; Yan-Ying Li; Yang-Yang Song; Meng-Ya Su
Journal:  Oncol Lett       Date:  2018-05-10       Impact factor: 2.967

3.  Multidrug resistance affects the prognosis of primary epithelial ovarian cancer.

Authors:  Bo Gao; Fengmei Yang; Wei Chen; Rui Li; Xiuxue Hu; Yong Liang; Dongmin Li
Journal:  Oncol Lett       Date:  2019-08-14       Impact factor: 2.967

4.  Prognostic and clinicopathological significance of Cacna2d1 expression in epithelial ovarian cancers: a retrospective study.

Authors:  Dandan Yu; Ruth Holm; Mariusz Adam Goscinski; Claes G Trope; Jahn M Nesland; Zhenhe Suo
Journal:  Am J Cancer Res       Date:  2016-09-01       Impact factor: 6.166

Review 5.  Low-grade epithelial ovarian cancer: what a radiologist should know.

Authors:  Sherif Elsherif; Sanaz Javadi; Chitra Viswanathan; Silvana Faria; Priya Bhosale
Journal:  Br J Radiol       Date:  2019-01-31       Impact factor: 3.039

Review 6.  Diagnostic performance of PET/CT and PET/MR in the management of ovarian carcinoma-a literature review.

Authors:  Mayur Virarkar; Dhakshinamoorthy Ganeshan; Anjalie Tara Gulati; Sarah Palmquist; Revathy Iyer; Priya Bhosale
Journal:  Abdom Radiol (NY)       Date:  2020-11-11

7.  EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA).

Authors:  Roberto C Delgado Bolton; Nicolas Aide; Patrick M Colletti; Annamaria Ferrero; Diana Paez; Andrea Skanjeti; Francesco Giammarile
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-07-03       Impact factor: 9.236

8.  MiR-506-3p suppresses the proliferation of ovarian cancer cells by negatively regulating the expression of MTMR6.

Authors:  Yuan Wang; Xia Lei; Chengying Gao; Yanxia Xue; Xiaolin Li; Haiying Wang; Yan Feng
Journal:  J Biosci       Date:  2019-12       Impact factor: 1.826

9.  Spatial cytotoxic and memory T cells in tumor predict superior survival outcomes in patients with high-grade serous ovarian cancer.

Authors:  Guodong Zhang; Qing Xu; Xiangyun Zhang; Moran Yang; Yiying Wang; Mengdi He; Jiaqi Lu; Haiou Liu
Journal:  Cancer Med       Date:  2021-05-05       Impact factor: 4.452

Review 10.  Comprehending the Proteomic Landscape of Ovarian Cancer: A Road to the Discovery of Disease Biomarkers.

Authors:  Shuvolina Mukherjee; Karin Sundfeldt; Carl A K Borrebaeck; Magnus E Jakobsson
Journal:  Proteomes       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.